News

Filter

Current filters:

None

Popular Filters

176 to 200 of 8858 results

Aptuit names Paul Overton executive vice president of business development and marketing

Aptuit names Paul Overton executive vice president of business development and marketing

16-07-2014

US-based drug development and discovery company Aptuit has appointed Paul Overton as executive vice president,…

AptuitBoardroomPharmaceuticalUSA

Sun Pharma acquires Pharmalucence

Sun Pharma acquires Pharmalucence

16-07-2014

Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, revealed that it has…

BSE SensexEconomy of IndiaGenericsIndiaMergers & AcquisitionsPharmalucenceProductionRanbaxy LaboratoriesSun Pharmaceuticals

Canada approves Pendopharm’s all-oral ribavirin treatment Ibavyr for hepatitis C

Canada approves Pendopharm’s all-oral ribavirin treatment Ibavyr for hepatitis C

16-07-2014

Quebec-based Pendopharm, a division of privately-held Canadian drugmaker Pharmascience, says the regulator…

Anti-viralsBiotechnologyCanadaIbavyrPendopharmPharmascienceRegulation

Breast cancer: DMP is largely consistent with guidelines, says IQWiG

Breast cancer: DMP is largely consistent with guidelines, says IQWiG

16-07-2014

The German Institute for Quality and Efficiency in Health Care (IQWiG) has today published the results…

Breast cancerGermanyInstitute for Quality and Efficiency in Health CareOncologyPharmaceuticalRegulation

CellAct Pharma receives orphan drug designation in EU for cancer drug

CellAct Pharma receives orphan drug designation in EU for cancer drug

16-07-2014

The European Medicines Agency’s Committee for Orphan Medicinal Products has granted German cancer specialists…

CAP7.1CellAct PharmaEuropeGermanyHepatologyOncologyPharmaceuticalRegulationTreatment of biliary tract cancers

BTG on track in 2nd-qtr financials

BTG on track in 2nd-qtr financials

16-07-2014

UK-based specialist health care company BTG has announced its interim management statement for the period…

BTGFinancialPharmaceuticalUKVarithena

Final funding boost for immatics to complete Phase III study

Final funding boost for immatics to complete Phase III study

16-07-2014

Germany’s privately-held immatics biotechnologies GmbH has received 22 million euros ($29 million)…

BiotechnologyFinancialGermanyimmatics biotechnologiesOncologyRenal cell carcinomaResearchSutent

Packaging and delivery specialist West opens first plant in India

Packaging and delivery specialist West opens first plant in India

16-07-2014

US packaging and delivery company West has dedicated its manufacturing plant in the Sri City Special…

ChennaiIndiaPharmaceuticalProductionSri CityWest

LEO Pharma strikes global dermatology deal with KLOK Tech

LEO Pharma strikes global dermatology deal with KLOK Tech

16-07-2014

Danish dermatology specialist LEO Pharma and Canada’s KLOX Technologies, both privately-held companies,…

Acne vulgarisDermatologicalsGlobalKLOX TechnologiesLEO PharmaLicensingPharmaceutical

New products drive 2nd-qtr growth for Johnson & Johnson

New products drive 2nd-qtr growth for Johnson & Johnson

15-07-2014

Global health care products giant Johnson & Johnson, the first pharma to report second-quarter 2014 financial…

Business FinanceFinancialJohnson & JohnsonMonoclonal antibodiesPharmaceuticalPrednisoneUSA

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

New Zealand to fund Norgine’s Xifaxan for hepatic encephalopathy

15-07-2014

New Zealand Pharmaceutical Management Agency PHARMAC has awarded a tender to Netherlands-headquartered…

Antibiotics and Infectious diseasesFinancialHealthcareNew ZealandNorginePharmaceuticalXifaxan

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil and Mexico

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil and Mexico

15-07-2014

Portuguese drugmaker BIAL and Brazil-based moksha8 have entered an exclusive license for the commercialization…

BIALBrazileslicarbazepineExaliefLicensingMexicoMoksha8NeurologicalPharmaceuticalPortugalZebinix

Codexis leaps on licensing deal with GlaxoSmithKline

Codexis leaps on licensing deal with GlaxoSmithKline

15-07-2014

Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, saw its share…

CodeEvolverCodeEvolver protein engineering platform technologyCodexisGlaxoSmithKlineLicensingPharmaceuticalProductionUK

Breakthrough therapy designation likely to positively influence oncologists

Breakthrough therapy designation likely to positively influence oncologists

15-07-2014

Breakthrough therapy designation is likely to positively influence perceptions of the drug for both oncologists…

Decision Resources GroupOncologyPharmaceuticalRegulationUSA

Ariad says PRAC requires additional data on Iclusig

Ariad says PRAC requires additional data on Iclusig

15-07-2014

US specialty pharma firm Ariad Pharmaceuticals says that the Pharmacovigilance Risk Assessment Committee…

Ariad PharmaceuticalsEuropeIclusigOncologyPharmaceuticalPharmacovigilance Risk Assessment CommitteeRegulation

176 to 200 of 8858 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top